Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -97.6% | -76.1% | 0 / 3 | +9.4% | +3.22 pp | -8.75 pp | +13.1% | 0.78 | 3.76 | 552 | +9,4% | 2,5 | −94,7% | 3.76 | 4.73 | −20,6% |
| Pts | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.470 (close price on 2026-10-19)EPS (TTM): 1.722
Financial charts
1.Revenue & growth
VND bn552Q2/26
1.Revenue & growth
VND bn552Q2/26
2.Profit & growth
VND bn1,12Q2/26
3.Profit mix (Penman)
VND bn270Q2/26
4.Margins & cost structure
%21.0%Q2/26
5.Returns & cash cycle
% · days10.4%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn4.205Q2/26
8.Funding & debt health
VND bn · times4.205Q2/26
9.Revenue backlog
VND bn209Q2/26
10.Valuation
times · %3,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %9Q2/26
Adjusted EPS growth, latest quarter
-97.6%
Average adjusted EPS growth, 3 quarters
-76.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26